Navigation Links
St. Louis Encephalitis Antibody, IgG by IFA, CSF

ProductsSt. Louis Encephalitis Antibody, IgG by IFA, CSF
Company ARUP Laboratories
Item St. Louis Encephalitis Antibody, IgG by IFA, CSF
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Louisville Elevator
2. Louisville Skin Hook
3. Encephalitis Antibody, St. Louis, IgG
4. Encephalitis Antibody, St. Louis IgG (CSF)
5. Encephalitis Antibody, St. Louis IgM (CSF)
6. Encephalitis Antibody, St. Louis IgM
7. St. Louis Encephalitis Antibody, IgG by IFA, Serum
8. St. Louis Encephalitis Antibody, IgM by IFA, CSF
9. St. Louis Encephalitis Antibody, IgM by IFA, Serum
10. California Encephalitis Antibody, IgG by IFA, CSF
11. California Encephalitis Antibody, IgM by IFA, CSF
Breaking Medicine News(10 mins):Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 3Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 4Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 5Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 2Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 3Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 4Health News:Sushi & Breastfeeding Join Birth Defects & Preterm Birth as Leading Concerns of Moms 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 3Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 4Health News:Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections 2Health News:Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections 3
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Sundia MediTech Appoints Dr Tong Xu as VP of Process Chemistry 12816 1Sundia MediTech Appoints Dr Tong Xu as VP of Process Chemistry 12816 2AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 1AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 2AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 3AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 4Tanning Chain Offers Tips for Effective Indoor and Outdoor Exposure 50246 1Tanning Chain Offers Tips for Effective Indoor and Outdoor Exposure 50246 2